Erenumab efficacy in highly resistant chronic migraine: a real-life study
- 1 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 41 (SUPPL 2), 457-459
- https://doi.org/10.1007/s10072-020-04658-1
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- European headache federation consensus on the definition of resistant and refractory migraineThe Journal of Headache and Pain, 2020
- Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experienceThe Journal of Headache and Pain, 2020
- A prospective real-world analysis of erenumab in refractory chronic migraineThe Journal of Headache and Pain, 2020